Summary of the International Conference on Onco-Nephrology: an emerging field in medicine.

Onco-nephrology is an emerging field in medicine. Patients with cancer may suffer from kidney diseases because of the cancer itself and cancer-related therapy. It is critical for nephrologists to be knowledgeable of cancer biology and therapy in order to be fully integrated in the multidisciplinary team and optimally manage patients with cancer and kidney diseases. In a recent international meeting, the key issues in this challenging clinical interface were addressed, including many unresolved basic science questions, such as the high tumor incidence in kidney transplant recipients. To this end, 70 highly qualified faculty members were gathered from all over the world to discuss these issues in 8 plenary sessions, including 5 keynote lectures. In addition, 48 young nephrologists and oncologists were invited to present their original observations that were highlighted in 2 large poster sessions.

• Publication year

  2019

• Venue

  Kidney International

• Publication date

  2019-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.KINT.2019.04.043PMID 31445584
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A quest for protecting kidneys from cisplatin toxicity.

  2019cited by this paper
• Nephrologists' perspectives on cancer screening in patients with chronic kidney disease: An interview study

  2019cited by this paper
• Do We Truly Care About the Functional Outcomes for Renal Cancer Patients? Multidisciplinarity Is Still Far Away.

  2019cited by this paper
• Systemic Treatment of Metastatic Clear Cell Renal Cell Carcinoma in 2018: Current Paradigms, Use of Immunotherapy, and Future Directions.

  2019cited by this paper
• Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts

  2019cited by this paper
• Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort study

  2018cited by this paper
• A study of 1088 consecutive cases of electrolyte abnormalities in oncology phase I trials

  2018cited by this paper
• Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update

  2018cited by this paper
• Renal cell carcinoma for the nephrologist.

  2018cited by this paper
• De novo NAD+ biosynthetic impairment in acute kidney injury in humans

  2018cited by this paper
• Below Safety Limits, Every Unit of Glomerular Filtration Rate Counts: Assessing the Relationship Between Renal Function and Cancer-specific Mortality in Renal Cell Carcinoma.

  2018cited by this paper
• Anti‐tumour actions of cannabinoids

  2018cited by this paper
• Extreme hypomagnesemia: characteristics of 119 consecutive inpatients

  2018cited by this paper
• Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma

  2018cited by this paper
• Practical issues for the management of hyponatremia in oncology

  2018cited by this paper
• Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.

  2018cited by this paper
• Hyponatremia associates with poor outcome in metastatic renal cell carcinoma patients treated with everolimus: prognostic impact

  2018cited by this paper
• The predictive potential of hyponatremia for glioblastoma patient survival

  2018cited by this paper
• Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events

  2018cited by this paper
• Sirtuins in Renal Health and Disease.

  2018cited by this paper
• Incorporating Cystatin C to Predict Methotrexate Elimination in Patients with CNS Lymphoma and Suspicious Renal Function

  2018cited by this paper
• New Model for Estimating Glomerular Filtration Rate in Patients With Cancer

  2017cited by this paper
• Hypercalcemia induces targeted autophagic degradation of aquaporin-2 at the onset of nephrogenic diabetes insipidus.

  2017cited by this paper
• Diagnosis of hyponatremia and increased risk of a subsequent cancer diagnosis: results from a nationwide population-based cohort study

  2017cited by this paper
• Hypercalcemia remains an adverse prognostic factor for newly diagnosed multiple myeloma patients in the era of novel antimyeloma therapies

  2017cited by this paper
• Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes

  2017cited by this paper
• Delay in Renal Hemodynamic Response to a Meat Meal in Severe Obesity

  2017cited by this paper
• Acute Kidney Injury in Patients with Cancer.

  2017cited by this paper
• Interrogating open issues in cancer precision medicine with patient-derived xenografts

  2017cited by this paper
• Tumour-induced osteomalacia

  2017cited by this paper
• Myeloma bone disease: pathogenesis and treatment.

  2017cited by this paper
• Adverse kidney effects of epidermal growth factor receptor inhibitors

  2017cited by this paper
• SIRT3-KLF15 signaling ameliorates kidney injury induced by hypertension

  2017cited by this paper
• Treatment Beyond Progression in Patients with Advanced Renal Cell Carcinoma Treated with Nivolumab in CheckMate 025.

  2017cited by this paper
• An integrated analysis of hyponatremia in cancer patients receiving platinum-based or nonplatinum-based chemotherapy in clinical trials (JCOG1405-A)

  2017cited by this paper
• Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases

  2017cited by this paper
• Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy

  2017cited by this paper
• Humanized Mouse Models of Clinical Disease.

  2017cited by this paper
• Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management

  2017cited by this paper
• Human mesenchymal stromal cells transplanted into mice stimulate renal tubular cells and enhance mitochondrial function

  2017cited by this paper
• Acute kidney injury and electrolyte disorders in the critically ill patient with cancer

  2017cited by this paper
• Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT‐1 and SALT‐2 trials

  2017cited by this paper
• Renal failure during chemotherapy: renal biopsy for assessing subacute nephrotoxicity of pemetrexed

  2017cited by this paper
• Euvolemic hyponatremia in cancer patients. Report of the Hyponatremia Registry: an observational multicenter international study

  2017cited by this paper
• Renal cancer.

  2016cited by this paper
• Acute kidney injury in critically ill cancer patients: an update

  2016cited by this paper
• Renal Function and All-Cause Mortality Risk Among Cancer Patients

  2016cited by this paper
• Mitochondrial Sirtuin 3 and Renal Diseases

  2016cited by this paper
• Electrolyte disorders associated with the use of anticancer drugs.

  2016cited by this paper
• Hyponatremia, all-cause mortality, and risk of cancer diagnoses in the primary care setting: A large population study.

  2016cited by this paper
• Onco-nephrology: a decalogue.

  2016cited by this paper
• Tumor lysis syndrome: review of pathogenesis, risk factors and management of a medical emergency

  2016cited by this paper
• Risk of Hyponatraemia in Cancer Patients Treated with Targeted Therapies: A Systematic Review and Meta-Analysis of Clinical Trials

  2016cited by this paper
• Prevalence of hypercalcemia among cancer patients in the United States

  2016cited by this paper
• Anticancer mechanisms of cannabinoids.

  2016cited by this paper
• Ectopic Cushing syndrome in small cell lung cancer: A case report and literature review

  2016cited by this paper
• Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds

  2016cited by this paper
• The occurrence of hyponatremia and its importance as a prognostic factor in a cross-section of cancer patients

  2016cited by this paper
• Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy

  2016cited by this paper
• Antineoplastic Treatment and Renal Injury: An Update on Renal Pathology Due to Cytotoxic and Targeted Therapies

  2016cited by this paper
• Deaths: Final Data for 2013.

  2016cited by this paper
• MicroRNA 193b-3p as a predictive biomarker of chronic kidney disease in patients undergoing radical nephrectomy for renal cell carcinoma

  2016cited by this paper
• Quantifying Glomerular Filtration Rates in Acute Kidney Injury: A Requirement for Translational Success.

  2016cited by this paper
• Mitochondria in Acute Kidney Injury.

  2016cited by this paper
• Endocannabinoids and Cancer.

  2015cited by this paper
• Sirtuin 3-dependent mitochondrial dynamic improvements protect against acute kidney injury.

  2015cited by this paper
• Denosumab: a new agent in the management of hypercalcemia of malignancy.

  2015cited by this paper
• Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial SIRT3

  2015cited by this paper
• High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response

  2015cited by this paper
• European Renal Best Practice Guideline on Kidney Donor and Recipient Evaluation and Perioperative Care

  2015cited by this paper
• Acute Kidney Injury

  2015cited by this paper
• Management and prevention of post-transplant malignancies in kidney transplant recipients

  2015cited by this paper
• Malignancy-related mortality following kidney transplantation is common.

  2014cited by this paper
• Genomic responses in mouse models greatly mimic human inflammatory diseases

  2014cited by this paper
• Electrolyte disorders associated with cancer.

  2014cited by this paper
• Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.

  2014cited by this paper
• Effects of Honokiol on Sepsis-Induced Acute Kidney Injury in an Experimental Model of Sepsis in Rats

  2014cited by this paper
• Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.

  2014cited by this paper
• Estimated risk of cancer transmission from organ donor to graft recipient in a national transplantation registry

  2014cited by this paper
• Patient-derived xenograft models: an emerging platform for translational cancer research.

  2014cited by this paper
• Reduced estimated GFR and cancer mortality.

  2014cited by this paper
• Relative risks of Chronic Kidney Disease for mortality and End Stage Renal Disease across races is similar

  2014cited by this paper
• De novo malignancies after organ transplantation: focus on viral infections.

  2013cited by this paper
• Acute Kidney Injury in Patients with Newly Diagnosed High-Grade Hematological Malignancies: Impact on Remission and Survival

  2013cited by this paper
• Spurious Electrolyte Disorders: A Diagnostic Challenge for Clinicians

  2013cited by this paper
• Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009.

  2013cited by this paper
• Carboplatin dose calculation in lung cancer patients with low serum creatinine concentrations using CKD-EPI and Cockcroft-Gault with different weight descriptors.

  2013cited by this paper
• Incidence rate, clinical correlates, and outcomes of AKI in patients admitted to a comprehensive cancer center.

  2013cited by this paper
• Genomic responses in mouse models poorly mimic human inflammatory diseases

  2013cited by this paper
• Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial.

  2013cited by this paper
• The frequency, cost, and clinical outcomes of hypernatremia in patients hospitalized to a comprehensive cancer center

  2013cited by this paper
• Calcitriol-mediated hypercalcemia: causes and course in 101 patients.

  2013cited by this paper
• Pazopanib versus sunitinib in metastatic renal-cell carcinoma.

  2013cited by this paper
• A comparison of measured and estimated glomerular filtration rate for carboplatin dose calculation in stage I testicular seminoma

  2013cited by this paper
• Estimation of renal function in lung cancer patients.

  2012cited by this paper
• Parathyroid hormone-related protein: an update.

  2012cited by this paper
• Patient-derived tumour xenografts as models for oncology drug development

  2012cited by this paper
• Evaluation of glomerular filtration rate estimation by Cockcroft-Gault, Jelliffe, Wright and Modification of Diet in Renal Disease (MDRD) formulae in oncology patients.

  2012cited by this paper
• Cholesterol-tethered platinum II-based supramolecular nanoparticle increases antitumor efficacy and reduces nephrotoxicity

  2012cited by this paper
• Onco-nephrology: renal toxicities of chemotherapeutic agents.

  2012cited by this paper

• Acute Kidney Injury in Hospitalized Cancer Patients: Single-Centre Real-Life Analysis of Incidence and Clinical Impact

  2026cites this paper
• Machine learning selection of basement membrane-associated genes and development of a predictive model for kidney fibrosis

  2025cites this paper
• Comparison of survival outcomes between kidney transplant and dialysis in patients with previous cancer.

  2025cites this paper
• Онконефрологічна допомога: чому вона необхідна і як її створити в Україні

  2024cites this paper
• Measurement of glomerular filtration rate in patients undergoing renal surgery for cancer: eGFR vs mGFR in the era of precision medicine.

  2024cites this paper
• Cancer before and after the start of hemodialysis and association with mortality – an Eastern-European multicenter study

  2023cites this paper
• Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022

  2023cites this paper
• Wall Tension and Tubular Resistance in Kidney Cystic Conditions

  2023cites this paper
• Breast cancer, alcohol, and phosphate toxicity

  2023cites this paper
• Construction and evaluation of risk prediction model for kidney injury in patients treated with PD-1 inhibitors.

  2023cites this paper
• The Onco-Nephrology Field: The Role of Personalized Chemotherapy to Prevent Kidney Damage

  2023influential citation
• Malignancy diseases and kidneys: A nephrologist prospect and updated review

  2023cites this paper
• Lung cancer-kidney crosstalk induces kidney injury, interstitial fibrosis, and enhanced cisplatin-induced nephrotoxicity.

  2023cites this paper
• Onconephrology: acute kidney disease after preventive ileostomy in a patient with colorectal cancer

  2023cites this paper
• Onconephrology: mitigation of renal injury in chemotherapy administration

  2023cites this paper
• Pharmacology of Tyrosine Kinase Inhibitors

  2023cites this paper
• Thrombotic microangiopathy – the importance of a multidisciplinary approach

  2023cites this paper
• Editorial: Women in onconephrology: 2022

  2023cites this paper
• The Nephrotoxicity of Drugs Used in Causal Oncological Therapies

  2022cites this paper
• A Prospective cross-sectional study estimated glomerular filtration rate from creatinine and cystatin C in adults with solid tumors.

  2022cites this paper
• Postoperative outcomes of cancer surgery in patients with and without kidney failure with dialysis therapy: a matched-pair cohort study

  2022cites this paper
• Development and organization of onco-nephrology in France, comment on “The path toward the creation of the American Society of Onco-Nephrology (ASON)”

  2022cites this paper
• Onco-nephrology: Physicians’ Expectations About a New Subspecialty

  2022cites this paper
• Serum cystatin C level can be used to estimate GFR in patients with solid tumors: Moderator Commentary

  2022cites this paper
• Nephrological management of renal cell carcinoma (RCC) patients: A narrative review

  2022cites this paper
• Renal toxicity of targeted therapies for renal cell carcinoma in patients with normal and impaired kidney function

  2021cites this paper
• Monographic consultation of onconephrology. Rationale and implementation.

  2021cites this paper
• Onconephrology

  2021cites this paper
• Impact of lenvatinib on renal function: long-term analysis of differentiated thyroid cancer patients

  2021cites this paper
• A new hypothesis to explain skin cancer risk in kidney allograft recipients

  2021cites this paper
• Acute kidney injury as a risk factor for mortality in oncological patients receiving check-point inhibitors.

  2021cites this paper
• Kidney injury and disease in patients with haematological malignancies

  2021cites this paper
• Current trends of anti-cancer molecular targeted therapies: a narrative review focusing on renal complications and their histological features.

  2021cites this paper
• Nephrotoxicity Associated with Novel Anticancer Agents (Aflibercept, Dasatinib, Nivolumab): Case Series and Nephrological Considerations

  2020influential citation
• Diagnostics, Risk Factors, Treatment and Outcomes of Acute Kidney Injury in a New Paradigm

  2020cites this paper
• Kidney Failure with Urinary Tract Cancers.

  2020cites this paper
• The renal adverse effects of cancer immunotherapy

  2020cites this paper
• Kidney involvement in monoclonal gammopathies: multidisciplinary approach in oncohematology and nephrology

  2020cites this paper
• [Palbociclib induces cell cycle arrest and senescence of human renal tubular epithelial cells in vitro].

  2020cites this paper
• Monographic consultation of onconephrology. Rationale and implementation.

  2020cites this paper
• Preventive strategies for acute kidney injury in cancer patients

  2020cites this paper
• The basics of onco-nephrology in the renal clinic

  2020cites this paper
• Urinalysis by combination of the dipstick test and urine protein–creatinine ratio (UPCR) assessment can prevent unnecessary lenvatinib interruption in patients with thyroid cancer

  2020cites this paper
• How to assess kidney function in oncology patients.

  2020cites this paper
• Kidney Transplant Modifies the Architecture and Microenvironment of Basal Cell Carcinomas

  2020cites this paper
• [Monoclonal gammopathy of renal significance: consensus of hematologists and nephrologists of Russia on the establishment of nosology, diagnostic approach and rationale for clone specific treatment].

  2019cites this paper
• Hypertension and renal disease prevention before cancer therapy

  year unknowncites this paper